Died: Bernard E. (Woody) Freamo, the first non-physician to serve as secretary general of the Canadian Medical Association, 1992 recipient of CMA's Medal of Honour, and the oft-described "father of MD Management," died Oct. 18 at the age of 85. Freamo joined CMA in 1957 to set up a department of economics and became Secretary General in 1982, serving 4 years before becoming executive vice-president of MD Management Ltd. (CMAJ 1986; 135:920-5 For now, Lilly is proposing to list payments made to physicians who serve as company speakers or advisors, while Merck says it will disclose speaking fees.
Lilly also indicated it hopes to expand the database by 2011 to include all information required by bipartisan legislation introduced by United States Senators Chuck Grassley (Republican-Iowa) and Herb Kohl (Democrat-Wisconsin), which would oblige drug, device and biologics manufacturers to reveal all financial payments, gifts, honoraria, travel and other handouts made to physicians.
Both firms say they have no current plans to include payments to Canadian physicians in their databases, although both anticipate moving to global reporting at an unspecified point in the future.
Grassley and Kohl's Physician Payments Sunshine Act was introduced in 2007 in an attempt to bring industry "influence-peddling out from the shadows." It proposed to create a national, publicly accessible database of all handouts over US$25, while imposing penalties ranging from US$10 000 to US$100 000 (per incident).
The drug industry assailed the legislation, arguing that it would restrict its ability to inform doctors about new drugs and create an "undue burden" because several states had already introduced reporting requirements with differing standards. With the legislation appearing to have stalled, Kohl sought to offset the criticism by cosponsoring a bill that would provide physicians with unbiased information about drugs by way of academic detailing (CMAJ 2007; 176[4] :429-31).
To further nullify opposition, in May 2008, Grassley and Kohl amended the legislation to override state reporting requirements and thus give industry a single, nation-wide reporting standard. They also raised the bar for the financial level of gifts that must be reported (to an aggregate of US$500 in a calendar year); significantly lowered the penalties for nonreporting (to US$1000 to $5000 per incident, with an annual cap of $50 000); excluded some items from reporting such as product samples, educational materials, and equipment loans, discounts and rebates; and proposed to Banned: Six months after proposing to ban the importation, sale and advertising of polycarbonate baby bottles which contain bisphenol A, Health Canada has announced it will draft regulations to that effect. The move does not prevent the use of bisphenol A in other consumer products, but the government says it will spend $1.7 million over the next 3 years to fund more bisphenol A research. 
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